Phase 2 Trial of Induction Gemcitabine,Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Phase 2 Trial of Induction Gemcitabine,Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer

Authors:	Nestor F. Esnaola Uzair B. Chaudhary Paul O'Brien Elizabeth Garrett-Mayer E. Ramsay Camp Melanie B. Thomas David J. Cole Alberto J. Montero Brenda J. Hoffman Joseph Romagnuolo Kelly P. Orwat David T. Marshall

Affiliation:	^∗ Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina;^† Division of Hematology and Oncology, Department of Internal Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina;^‡ Division of Biostatistics and Epidemiology, Department of Internal Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina;^§ Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina;^‖ Department of Radiation Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！